295 related articles for article (PubMed ID: 16682379)
1. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.
Williams MH; Handler CE; Akram R; Smith CJ; Das C; Smee J; Nair D; Denton CP; Black CM; Coghlan JG
Eur Heart J; 2006 Jun; 27(12):1485-94. PubMed ID: 16682379
[TBL] [Abstract][Full Text] [Related]
2. Screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertension: a systematic review.
Gladue H; Altorok N; Townsend W; McLaughlin V; Khanna D
Semin Arthritis Rheum; 2014 Feb; 43(4):536-41. PubMed ID: 24012044
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme.
Morrisroe K; Stevens W; Sahhar J; Rabusa C; Nikpour M; Proudman S;
Arthritis Res Ther; 2017 Mar; 19(1):42. PubMed ID: 28270192
[TBL] [Abstract][Full Text] [Related]
4. Sildenafil Versus Placebo for Early Pulmonary Vascular Disease in Scleroderma (SEPVADIS): protocol for a randomized controlled trial.
Lammi MR; Mukherjee M; Saketkoo LA; Carey K; Hummers L; Hsu S; Krishnan A; Sandi M; Shah AA; Zimmerman SL; Hassoun PM; Mathai SC
BMC Pulm Med; 2024 Apr; 24(1):211. PubMed ID: 38689245
[TBL] [Abstract][Full Text] [Related]
5. Echocardiography may help detect pulmonary vasculopathy in the early stages of pulmonary artery hypertension associated with systemic sclerosis.
Serra W; Chetta A; Santilli D; Mozzani F; Dall'Aglio PP; Olivieri D; Cattabiani MA; Ardissino D; Gherli T
Cardiovasc Ultrasound; 2010 Jul; 8():25. PubMed ID: 20598164
[TBL] [Abstract][Full Text] [Related]
6. Right heart failure as a cause of pulmonary congestion in pulmonary arterial hypertension.
D'Alto M; Di Maio M; Argiento P; Romeo E; Rea G; Liccardo B; Del Giudice C; Vergara A; Caiazza E; Del Vecchio GE; Di Vilio A; Gargani L; D'Andrea A; Bossone E; Golino P; Picano E; Naeije R
Eur J Heart Fail; 2024 Apr; 26(4):817-824. PubMed ID: 38404257
[TBL] [Abstract][Full Text] [Related]
7. Impact of Epicardial Adipose Tissue on Right Cardiac Function and Prognosis in Pulmonary Arterial Hypertension.
Chen Y; Li J; Li F; Chen Z; Chen Z; Luo J; Qiu H; Chen W; Hu J; Luo X; Tan Y; Rathinasabapathy A; Chen J; Li J
Chest; 2024 May; 165(5):1211-1223. PubMed ID: 38040053
[TBL] [Abstract][Full Text] [Related]
8. Assessment of pulmonary arterial stiffness in patients with systemic sclerosis without overt pulmonary hypertension.
Çoksevim M; Çerik İB; Yenerçağ M; Kocasarı AO; Yavuzbilge G; Polat M; Meriç M; Özgen M
Int J Cardiovasc Imaging; 2022 Oct; 38(10):2191-2197. PubMed ID: 37726465
[TBL] [Abstract][Full Text] [Related]
9. Performance of DETECT Pulmonary Arterial Hypertension Algorithm According to the Hemodynamic Definition of Pulmonary Arterial Hypertension in the 2022 European Society of Cardiology and the European Respiratory Society Guidelines.
Distler O; Bonderman D; Coghlan JG; Denton CP; Grünig E; Khanna D; McLaughlin VV; Müller-Ladner U; Pope JE; Vonk MC; Di Scala L; Lemarie JC; Perchenet L; Hachulla É
Arthritis Rheumatol; 2024 May; 76(5):777-782. PubMed ID: 38146100
[TBL] [Abstract][Full Text] [Related]
10. Peripheral microvascular function is linked to cardiac involvement on cardiovascular magnetic resonance in systemic sclerosis-related pulmonary arterial hypertension.
Vos JL; Lemmers JMJ; El Messaoudi S; Snoeren M; van Dijk APJ; Duijnhouwer AL; Rodwell L; van Leuven SI; Post MC; Vonk MC; Nijveldt R
Eur Heart J Cardiovasc Imaging; 2024 Apr; 25(5):708-717. PubMed ID: 38170546
[TBL] [Abstract][Full Text] [Related]
11. Survival in systemic sclerosis associated pulmonary arterial hypertension in the current treatment era-results from a nationwide study.
Sarı A; Satış H; Ayan G; Küçükşahin O; Kalyoncu U; Fidancı AA; Ayvalı MO; Ata N; Ülgü MM; Birinci Ş; Akdoğan A
Clin Rheumatol; 2024 Jun; 43(6):1919-1925. PubMed ID: 38676757
[TBL] [Abstract][Full Text] [Related]
12. Increased right atrial volume measured with cardiac magnetic resonance is associated with worse clinical outcome in patients with pre-capillary pulmonary hypertension.
Bredfelt A; Rådegran G; Hesselstrand R; Arheden H; Ostenfeld E
ESC Heart Fail; 2018 Oct; 5(5):864-875. PubMed ID: 29916558
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary arterial hypertension associated with systemic sclerosis.
Mathai SC; Hassoun PM
Expert Rev Respir Med; 2011 Apr; 5(2):267-79. PubMed ID: 21510736
[TBL] [Abstract][Full Text] [Related]
14. Undiagnosed connective tissue diseases: High prevalence in pulmonary arterial hypertension patients.
Cavagna L; Codullo V; Ghio S; Scirè CA; Guzzafame E; Scelsi L; Rossi S; Montecucco C; Caporali R
Medicine (Baltimore); 2016 Sep; 95(39):e4827. PubMed ID: 27684814
[TBL] [Abstract][Full Text] [Related]
15. Application of homocysteine as a non-invasive and effort-free measurements for risk assessment of patients with pulmonary hypertension.
Wang MT; Chi PL; Cheng CC; Huang WC; Chen LW
Cardiol J; 2024; 31(2):285-299. PubMed ID: 37772357
[TBL] [Abstract][Full Text] [Related]
16. Kynurenine pathway metabolism evolves with development of preclinical and scleroderma-associated pulmonary arterial hypertension.
Simpson CE; Ambade AS; Harlan R; Roux A; Aja S; Graham D; Shah AA; Hummers LK; Hemnes AR; Leopold JA; Horn EM; Berman-Rosenzweig ES; Grunig G; Aldred MA; Barnard J; Comhair SAA; Tang WHW; Griffiths M; Rischard F; Frantz RP; Erzurum SC; Beck GJ; Hill NS; Mathai SC; Hassoun PM; Damico RL;
Am J Physiol Lung Cell Mol Physiol; 2023 Nov; 325(5):L617-L627. PubMed ID: 37786941
[TBL] [Abstract][Full Text] [Related]
17. Plasma aldosterone levels are elevated in patients with pulmonary arterial hypertension in the absence of left ventricular heart failure: a pilot study.
Maron BA; Opotowsky AR; Landzberg MJ; Loscalzo J; Waxman AB; Leopold JA
Eur J Heart Fail; 2013 Mar; 15(3):277-83. PubMed ID: 23111998
[TBL] [Abstract][Full Text] [Related]
18. Subclinical coronary atherosclerosis, detected by computer tomography with coronary calcium score, and the occurrence of major cardiovascular events at 5 years of follow-up in a cohort of patients with systemic sclerosis.
Rotondo C; Sciacca S; Rella V; Busto G; Colia R; Cantatore FP; Corrado A
Eur J Intern Med; 2023 Sep; 115():62-69. PubMed ID: 37316356
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of pericardial effusion in systemic sclerosis-associated pulmonary hypertension: analysis from the PHAROS Registry.
Luo Y; Gordon JK; Xu J; Kolstad KD; Chung L; Steen VD; Bernstein EJ;
Rheumatology (Oxford); 2024 May; 63(5):1251-1258. PubMed ID: 37478347
[TBL] [Abstract][Full Text] [Related]
20. Ten-year outcome of chronic thromboembolic pulmonary hypertension patients in a tertiary center.
Küçükoğlu MS; Sinan ÜY; Yıldızeli B
Anatol J Cardiol; 2020 Jan; 23(2):105-109. PubMed ID: 32011330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
